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Abstract
Previous studies have shown that CCL2/CX3CR1 deficient mice on C57BL/6N background (with rd8 mutation) have an early
onset (6 weeks) of spontaneous retinal degeneration. In this study, we generated CCL22/2CX3CR1GFP/GFP mice on the
C57BL/6J background. Retinal degeneration was not detected in CCL22/2CX3CR1GFP/GFP mice younger than 6 months.
Patches of whitish/yellowish fundus lesions were observed in 17,60% of 12-month, and 30,100% of 18-month CCL22/
2CX3CR1GFP/GFP mice. Fluorescein angiography revealed no choroidal neovascularisation in these mice. Patches of retinal
pigment epithelium (RPE) and photoreceptor damage were detected in 30% and 50% of 12- and 18-month CCL22/
2CX3CR1GFP/GFP mice respectively, but not in wild-type mice. All CCL22/2CX3CR1GFP/GFP mice exposed to extra-light
(,800lux, 6 h/day, 6 months) developed patches of retinal atrophy, and only 20–25% of WT mice which underwent the
same light treatment developed atrophic lesions. In addition, synaptophysin expression was detected in the outer nucler
layer (ONL) of area related to photoreceptor loss in CCL22/2CX3CR1GFP/GFP mice. Markedly increased rhodopsin but reduced
cone arrestin expression was observed in retinal outer layers in aged CCL22/2CX3CR1GFP/GFP mice. GABA expression was
reduced in the inner retina of aged CCL22/2CX3CR1GFP/GFP mice. Significantly increased Mu¨ller glial and microglial
activation was observed in CCL22/2CX3CR1GFP/GFP mice compared to age-matched WT mice. Macrophages from CCL22/
2CX3CR1GFP/GFP mice were less phagocytic, but expressed higher levels of iNOS, IL-1b, IL-12 and TNF-a under hypoxia
conditions. Our results suggest that the deletions of CCL2 and CX3CR1 predispose mice to age- and light-mediated retinal
damage. The CCL2/CX3CR1 deficient mouse may thus serve as a model for age-related atrophic degeneration of the RPE,
including the dry type of macular degeneration, geographic atrophy.
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Introduction
Age-related macular degeneration (AMD) is a disease, in which
the neuronal retina of the macula gradually degenerates with age
resulting in the loss of central vision [1]. Clinically, the disease
presents with the accumulation of drusen, yellowish deposits in the
macula between the retinal pigment epithelium (RPE) and Bruch’s
membrane [1], or reticular pseudo-drusen at the subretinal space
[2,3]. The disease may progress to two advanced forms, geo-
graphic atrophy (dry AMD) where gradual vision loss occurs due
to RPE and photoreceptor cell death, and neovascular AMD (wet
AMD) where visual loss is sudden due to haemorrhage or fluid
leakage from a subretinal neovascular membrane. The pathogen-
esis of AMD is not fully understood.
Compelling evidence suggests that inflammation may play
a causal role in AMD [4–6]. Genetic studies have shown that the
risk of AMD is related to polymorphisms of a number of immune
related genes, including complement factor H (CFH)[7–10],
complement component 2 and factor B (C2/CFB) [11], comple-
ment component 3 (C3)[12–14], Toll-like receptor (TLRs) [15],
and fractalkine receptor (CX3CR1) genes[16–19], although a re-
cent study by Zerbib et al did not confirm the association between
CX3CR1 polymorphism (T280M) and neovascular AMD in
a French population [20]. Drusen, the hall-mark of early AMD,
contains many components that can stimulate an inflammatory
response in the RPE/Brusch’s membrane layer, with recruitment
of macrophages [21,22]. A recent study has shown that anti-
inflammatory therapy in combination with anti-VEGF treatment
may provide additional benefits (as compared to anti-VEGF alone)
to wet-AMD [23] However, the underlying mechanism related to
inflammation in AMD remains ill-defined.
We have shown previously that a para-inflammatory response,
characterized by microglial activation and subretinal migration,
and complement activation, is a part of normal retinal homeostasis
during aging [24–26]. Under chronic stress conditions, retinal
para-inflammation may also involve the recruitment of bone
marrow-derived myeloid cells induced by CCL2-CCR2 ligation
[27]. In the absence of CCL2 or CCR2, age-related retinal para-
inflammation is dysregulated, and is related to the development of
dry AMD-like lesions in these mice [28,29]. Furthermore, mice
deficient in CX3CR1 age-dependently develop AMD-like lesions
[16], and mice deficient in both CCL2 and CX3CR1 have an
early onset of retinal degeneration [30], although recent studies
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suggest that pathologies in the CCL2/CX3CR1 double knockout
(DKO) mice is related to the Crb1 rd8 mutation [31,32]. The
above evidence suggests that the malfunction of the chemokine
ligand-receptor pairs CCL2-CCR2, or CX3CL1-CX3CR1 may
be related to the dysregulated retinal para-inflammation and
retinal lesion development under aging conditions. In contrast to
the above observations, other studies failed to detect retinal lesions
in these mice. Luhmann et al observed increased subretinal
macrophage accumulation but no retinal degeneration in aged (up
to 25 months) CCL2 KO mice [33]. The group also reported no
retinal degeneration in 12–14 months old CCL2 KO, CX3CR1
KO and CCL2/CX3CR1 DKO mice housed under dim
conditions (33 lux light intensity) [34]. Vessey et al, however,
observed inner retinal (amacrine cell) dysfunction in 9-month old
CCL2/CX3CR1GFP/GFP mice [35]. The role of the CCL2-CCR2
and CX3CL1-CX3CR1 chemokine ligand-receptor pairs in the
age-related retinal para-inflammatory response and their contri-
bution to age-related AMD-like retinal lesion development
warrant further investigation.
In this study, we generated the double knockout (DKO)
CCL22/2CX3CR1GFP/GFP reporter mice on the C57/BL6/J
background which does not express the rd8 mutation. The mice
are deficient in both CCL2 and CX3CR1, and express GFP in
myeloid-derived cells, which readily allows myeloid cell detection.
We show that the CCL22/2CX3CR1GFP/GFP mice age-de-
pendently develop localised RPE and photoreceptor atrophy akin
to the human geographic atrophy (GA) dry type of AMD. More
importantly, we found that GA-like lesions in these mice can be
further enhanced by environmental risk factors such as light.
Retinal lesion development is related to enhanced microglial
activation and altered myeloid cell function in these mice.
Materials and Methods
Generation of CCL22/2CX3CR1GFP/GFP Mice
CCL22/2 mice (B6.129S4-Ccl2tm1Rol/J, Jackson Laboratory,
Bar Harbor, USA) and CX3CR1GFP/GFP mice [36] were used as
founder generations (F0). The offspring mice (F1) were inter-
crossed to obtain CCL22/2CX3CR1GFP/GFP mice. Mice geno-
types were confirmed by PCR. DNA sequencing confirmed that
all mice (WT, F0 founders and CCL22/2CX3CR1GFP/GFP mice)
do not have Crb1 gene rd8 mutation.
CCL22/2CX3CR1GFP/GFP mice were maintained in standard
animal housing rooms with 12 h light-dark cycle. In some
experiment, 4 months old mice were exposed to ,800 lux during
their 12 h-light cycle, 6 h/day for 6 months. All in vivo
procedures were under the regulation of UK Home Office
Animals (Scientific Research) Act 1986, and approved by the
Ethical Review Committee of Queen’s University Belfast (Project
Licence Number: PPL 2664). The study was conducted in
compliance with the Association for Research in Vision &
Ophthalmology Statement for the Use of Animals in Ophthal-
mology and Vision Research.
Clinical Investigations
Fundus imaging: A topic endoscopic fundus imaging (TEFI)
system described previously [37,38] was used to obtain fundus
images at different times (1.5, 3, 6, 9, 12, and 18 month). Images
were captured using the Nikon D90 camera and saved in TIFF
format. Adobe Photoshop (Version 6.0) software was used to adjust
image brightness and contrast.
Indocyanine green (ICG) angiography: Mice were anesthetized
with ketamine hydrochloride (60 mg/kg, ip, Fort George Animal
Centre, Southampton, United Kingdom), and xylazine (5 mg/kg,
ip, Pharmacia & Veterinary Products, Kiel, Germany). Pupils were
dilated using 1% tropicamide and 2.5% phenylephrine (Chauvin,
Essex, UK). 100 ml of 2.5% of ICG (American Biochemical &
Pharmaceuticals Ltd, Surrey, UK) was injected through the tail
vein, and angiographic images were captured using the HRA2
system (Heidelberg Engineering Ltd, Hemel Hempstead, UK).
Induction of Choroidal Neovascularisation
Mice were anesthetised and pupils were dilated as above
described. Three 532 diode laser spots (100 mm spot size,
100 msec, 200 mW) were applied to each fundus to induce
choroidal neovascularisation (CNV). The rupture of Bruch’s
membrane was confirmed by the production of a vaporization
bubble at the time of laser treatment. Ten days later, mice were
sacrificed and eyes were harvested for RPE/choroidal flatmount
investigation (see below).
Retinal Pigment Epithelial cell Isolation and Culture
RPE cells were isolated from 3-month old WT and DKO mice
using a protocol described previously [39,40]. In brief, retinas
were removed from mouse eye-cups. The eyecups were then
immersed in 0.5% trypsin-EDTA (INC Flow, Irvine, CA) at 37uC
for 45 minutes. RPE cells were released from eyecups by gentle
aspiration. The detached RPE cells were then cultured in DMEM
supplemented with 10% fetal calf serum (Sigma, Cambridge, UK)
for 6 days and passaged when reaching confluence. 3rd passage
RPE cells were used to detect VEGF-165 mRNA expression.
Table 1. Primer sequences for real time RT-PCR.
Genes Forward Reverse
C1qb ATAAAGGGGGAGAAAGGGCT CGTTGCGTGGCTCATAGTT
C3 AGCAGGTCATCAAGTCAGGC GATGTAGCTGGTGTTGGGCT
C4 ACCCCCTAAATAACCTGG CCTCATGTATCCTTTTTGGA
CFH CGTGAATGTGGTGCAGATGGG AGAATTTCCACACATCGTGGCT
CFB CTCCTCTGGAGGTGTGAGCG GGTCGTGGGCAGCGTATTG
C1INH TTGAGTGCCAAGTGGAAGATAAC GTGCTTTGGGAACACGGGTAC
CD59a TGTCTAGAGCAGGATCTAGC ATCCGTCACTTTTGTTACAC
IL-10 TGCAGGACTTTAAGGGTTACTTGG GGCCTTGTAGACACCTTGGTC
IL-1b TCCTTGTGCAAGTGTCTGAAGC ATGAGTGATACTGCCTGCCTGA
IL-6 TCTGCAAGAGACTTCCATCCAGT TCTGCAAGTGCATCATCGTTGT
IL12P40 GACATCATCAAACCAGACCCGCC GCCTTTGCATTGGACTTCGGT
TNF-a GCCTCTTCTCATTCCTGCTT CTCCTCCACTTGGTGGTTTG
iNOS GGCAAACCCAAGGTCTACGTT TCGCTCAAGTTCAGCTTGGT
Arg1 TTATCGGAGCGCCTTTCTCAA TGGTCTCTCACGTCATACTCTGT
VEGFa CCCACGTCAGAGAGCAACAT TTTCTTGCGCTTTCGTTTTT
CCL2 AGGTCCCTGTCATGCTTCTG TCTGGACCCATTCCTTCTTG
CCL5 ACTCCCTGCTGCTTTGCCTAC GAGGTTCCTTCGAGTGACA
CXCL2 AAGTTTGCCTTGACCCTGAA AGGCACATCAGGTACGATCC
CXCL10 GGATGGCTGTCCTAGCTCTG ATAACCCCTTGGGAAGATGG
CXCL12 AAACCAGTCAGCCTGAGCTACC GGCTCTGGCGATGTGGC
CX3CL1 ACGAAATGCGAAATCATGTGC CTGTGTCGTCTCCAGGACAA
NLRP3 ATTACCCGCCCGAGAAAGG TCGCAGCAAAGATCCACACAG
18s AGGGGAGAGCGGGTAAGAGA GGACAGGACTAGGCGGAACA
b-actin CCTTCCTTCTTGGGTATG TGTAAAACGCAGCTCAGTAA
doi:10.1371/journal.pone.0061381.t001
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Retinal or RPE/Choroidal Flatmount Preparation
Mouse eyes were fixed with 2% paraformaldehyde (Agar
Scientific Ltd. Cambridge, UK) for 2 h. Retina and RPE/choroid
were then dissected and processed for wholemount staining as
previously described [41,42]. In brief, retinal tissues were
permeabilized with 0.3% triton X-100 for 2,4 h and RPE/
choroidal tissues for 1 h at room temperature. Retinal tissues were
then incubated with biotin-conjugated isolectin B4 (1:100 in 0.1%
triton X-100/PBS, Vector Lab, USA) overnight, followed by R-PE
conjugated straptavidine (1:100, Invitrogen, Paisley, UK). RPE/
choroidal tissues from normal aging eyes were incubated with
Rhodamine-conjugated phalloidin (1:100, Invitrogen Molecular
Probes, Paisley, UK) at 4uC for 3 h. RPE/choroidal tissues from
CNV-induced eyes were incubated with biotinylated isolectin B4
(1:100, Vector Laboratories Ltd, Peterborough, UK) and rabbit
anti-mouse collagen IV (1:100, ABD Serotec Ltd. Oxford, UK) in
0.1% Triton X-100 at 4uC, overnight, followed by FITC-
streptavidin (1:200, Vector Laboratories Ltd) and goat anti-rabbit
Alex Fluor 594 (1:200, Invitrogen, Paisley, UK) for 2 h at room
temperature. After thorough washes, samples were flat-mounted
on glass slides and examined by confocal microscopy (C1 Nikon
Confocal Microscope, Eclipse TE200-U, Nikon UK Ltd, Surry,
UK). Confocal images were analysed using the NIS Element
(Nikon UK Ltd, Surry, UK) imaging analysis software.
Immunohistochemistry
Mouse eyes were fixed with 2% paraformaldehyde for 2 h. Eyes
were then transferred to a 30% sucrose solution in PBS for 24 h at
4uC and embedded in Optimum Cutting Temperature (OCT)
media (Sakura Finetek, Torrance, USA). Fourteen micrometer
thick cryosections were blocked with 10% fetal calf serum (FCS) in
1% Triton X-100/PBS for 1 h. Sections were then incubated with
Figure 1. Retinal lesion in CCL22/2CX3CR1GFP/GFP mice. (A–F) Fundus image from 6-month (A), 12-month (B, C), 18-month (D), 10-month+light
(E) CCL22/2CX3CR1GFP/GFP mice, and 18-month WT mice (F). Arrows indicate retinal lesions. (G, H) Indocyanine green angiography showing retinal (G)
and choroidal (H) circulation of an 18-month old CCL22/2CX3CR1GFP/GFP mouse. CNV was not observed in CCL22/2CX3CR1GFP/GFP mice.
doi:10.1371/journal.pone.0061381.g001
Table 2. Retinal lesion in different experiments under normal housing conditions.
Exp Mice (No. & strain) Average light intensity (lux)*
No. of mice with retinal lesion at 12
months (%)
No. of mice with retinal lesion at 18 months
(%)
1 WT: n = 12 46 (n = 6) 0 (0%) 0 (0%)
98 (n = 6) 0 (0%) 0 (0%)
DKO: n = 12 46 (n = 6) 1 (17%) 2 (30%)
98 (n = 6) 3 (50%) 3 (50%)
2 WT: n = 7 120 0 (0%) 0 (0%)
DKO: n = 6 120 2 (30%) 4 (67%)
3 WT: n = 10 180 0 (0%) 0 (0%)
DKO: n = 10 180 6 (60%) 10 (100%)
*, Light intensity was the average of measurements taken from 5 different areas inside the cage: front, middle, rear, under the food, under the water box.
doi:10.1371/journal.pone.0061381.t002
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rabbit polyclonal anti-cone arrestin (AB15282, Chemicon; Teme-
cula, CA dilution 1:10000), mouse monoclonal anti-rhodopsin
(clone 4D2, Chemicon; dilution 1:500), rabbit polyclonal anti-
human synaptophysin (N1566, Dako UK Ltd, Cambridge, UK;
dilution 1:200), rabbit polyclonal anti-glial fibrillary acidic protein
(GFAP, AB7260, Abcam, Cambridge, UK; dilution 1:500), guinea
pig polyclonal anti-c-aminobutyric acid (GABA, AB175, Chemi-
con; dilution 1:500) or goat polyclonal anti-glycine transporter 1
(GlyT1, AB1770, Chemicon; dilution 1:5000) overnight at 4uC.
After washing, sections were incubated for 2 h with Alexa Fluor
594 donkey anti-rabbit IgG (1:200, Invitrogen) or Alexa Fluor 488
donkey anti-mouse IgG (1:200, Invitrogen). Samples were cover-
slipped with Vectashield mounting medium with DAPI (Vector
Laboratories) and examined by confocal microscopy (C1 Nikon
Confocal Microscope, Eclipse TE200-U).
Histology
Mouse eyes were fixed in 2.5% glutaraldehyde for at least 3
days. Eye-cups were dissected into small pieces, and post-fixed in
1% osmium tetroxide in sodium cacodylate buffer for 1 h.
Samples were then dehydrated through ascending ethanol washes
(50% to 100%) and infiltrated with 100% agar low viscosity resin
(LVR, Agar) overnight. Samples were embedded in LVR and
incubated at 60uC for 48 h. Semithin sections (1 mm) were cut
using the Leica Ultracut UCT microtome (Leica Microsyetems
Ltd. Milton Keynes, UK), and stained with 1% toluidine blue
(Sigma-Aldrich), and examined by light microscopy (Nikon Eclipse
E400).
Ultrathin sections (80 nm) were prepared for transmission
electron microscopy. Sections were loaded onto 200 mesh copper
grids and stained with uranyl acetate saturated solution and 2.5%
Table 3. Retinal lesion in mice that were exposed to 800lux light.
Exp Mice (No. & strain) Light treatment start age
No. of mice with retinal lesion at 6
months (%)
No. of mice with retinal lesion at 10 months
(%)
1 WT: n = 10 4-month 0 (0%) 2 (20%)
DKO: n = 12 4-month 3 (25%) 10 (83%)
2 WT: n = 8 3-month 0 (0%) 2 (25%)
DKO: n = 8 3-month 4(50%) 8 (100%)
doi:10.1371/journal.pone.0061381.t003
Figure 2. Choroidal neovascularisation in CCL22/2CX3CR1GFP/GFP DKO mice. (A) CNV was induced in adult (8,12-week) WT and CCL22/
2CX3CR1GFP/GFP mice. RPE/choroidal flatmounts were collected at day 10 and stained for isolectin B4 (green) and collagen IV (red) and examined by
confocal microscopy. (B) CNV size in WT and CCL22/2CX3CR1GFP/GFP mice at day 10. N = 6. (C, D) VEGF-A mRNA expression in RPE cells (C) and BM-
DMs (D) from WT and CCL22/2CX3CR1GFP/GFP mice. N = 5.
doi:10.1371/journal.pone.0061381.g002
CCL2 and CX3CR1 in Retinal Degeneration
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e61381
Figure 3. Retinal pigment epithelium (RPE) damage, photoreceptor degeneration and amacrine cell alteration in CCL22/
2CX3CR1GFP/GFP mice. (A–F) Confocal images of RPE/choroidal flatmount from 12-month WT (A), 12-month CCL22/2CX3CR1GFP/GFP (B), 18-month
CCL2 and CX3CR1 in Retinal Degeneration
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lead citrate. Samples were visualized using a FEI Philips CM 100
transmission electron microscope (FEI, Eindhoven, the Nether-
lands) operating at 100 kV.
Culture of Bone Marrow-derived Macrophages
Bone marrow-derived macrophages (BMDMs) were cultured as
previously described [28]. In brief, bone marrow cells were
collected from mouse tibias and femurs and red blood cells were
removed with lysis buffer (0.75% NH4Cl, 0.2% Tris–HCl,
PH 7.2). Cells were then cultured in Dulbecco’s modification of
Eagle’s medium (DMEM; Gibco BRL, Paisley, UK) supplemented
with 15% fetal calf serum (Sigma-Aldrich) and 15% L929
conditioned medium at 37uC in 5% CO2 incubator for 5 days.
BMDMs (M0) were polarized into M1 (by 50 ng/ml LPS, Sigma-
Aldrich) or M2 (by 20 ng/ml IL4, R&D systems, UK) macro-
phages. In some experiments, BMDMs were cultured in 1%
oxygen chamber for 8 h prior total RNA extraction.
Phagocytosis Assay
BMDMs were seeded into a 96-well plate at the density of
16105/200 ml/well). The phagocytosis assay was performed using
the pHrodoTM E Coli Bioparticles Kit (Invitrogen) according to
the manufacturer’s instructions. Fluorescence intensity was mea-
sured at different time points using Tecan Microplate reader
(Tecan Group Ltd. Mannedorf, Switzerland) with 550 nm
excitation wavelength and a 600 nm emission filter. Bioparticle
conjugates alone acted as a background control. Net phagocytosis
was calculated by subtracting the average fluorescence intensity of
the negative control wells (particles without cells) from the
experimental wells.
CCL22/2CX3CR1GFP/GFP (C), and 10-month+light CCL22/2CX3CR1GFP/GFP (D, E) and 10-month+light WT (F) mice. Arrows in (E) indicate RPE vacuoles in
z-stack images. Scale bar = 50 mm. (G) The average number of RPE lesion in different groups of mice. N $6, unpaired Student t test. #, no lesions
were detected. (H–J) semithin retinal sections from 18-month WT (H), 18-month CCL22/2CX3CR1GFP/GFP (I) and 10-month+light CCL22/2CX3CR1GFP/
GFP mice (J). ONL, outer nuclear layer; OS, outer segments; Ch, choroid. Asterisks indicate RPE vacuoles. (K, L) Synaptophysin expression in 18-month
WT (K) and 18-month CCL22/2CX3CR1GFP/GFP (L) mouse retina. OPL, outer plexiform layer; INL, inner nuclear layer. Synaptophysin was observed in
ONL in aged CCL22/2CX3CR1GFP/GFP mice (arrowheads, L). (M, N) Rhodopsin expression in 18-month WT (M) and CCL22/2CX3CR1GFP/GFP (N) mouse
retina. Rhodopsin was detected in OPL and ONL layers in aged CCL22/2CX3CR1GFP/GFP mouse (N). (O, P) Cone arrestin expression in 18-month WT (O)
and CCL22/2CX3CR1GFP/GFP (P) mouse retina. (Q, R) Glycine transporter 1 (green) and GABA (red) immunoreactivities in 12-month WT (Q) and CCL22/
2CX3CR1GFP/GFP (R) mouse retina. A marked reduction in GABA expression was noted in the IPL of CCL22/2CX3CR1GFP/GFP mouse retina. GCL,
ganglion cell layer. Scale bar = 25 mm.
doi:10.1371/journal.pone.0061381.g003
Figure 4. Transmission electron microscopic (TEM) images of mouse eyes. (A) Image from an 18-month WT mouse. (B) Image from an 18-
month CCL22/2/CX3CR1GFP/GFP mouse. (C) The average thickness of Bruch membrane in WT and CCL22/2/CX3CR1GFP/GFP mice. N = 6 (eyes). (D)
Vacuolated changes in RPE mitochondria from CCL22/2/CX3CR1GFP/GFP mice. (E) Vacuolated changes (asterisks) in RPE cells in CCL22/2CX3CR1GFP/GFP
mice. (F) Photoreceptor inner segment damage (arrow) in CCL22/2CX3CR1GFP/GFP mice. (G) Photoreceptor inner segment damage (arrows) and outer
segment disorientation (arrowheads) in an area without vacuolated RPE damage. BM, Bruch membrane; CP, choroidal capillaries; RPE, retinal pigment
epithelium.
doi:10.1371/journal.pone.0061381.g004
CCL2 and CX3CR1 in Retinal Degeneration
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e61381
Flow Cytometry
Blood samples were collected from 3- and 18-month old
CCL22/2CX3CR1GFP/GFP mice and WT C57/BL6J mice. 50 ml
volumes of blood were incubated with antibody cocktails contain-
ing rat anti-mouse MCH class II (I-A/I-E, M5/114.15.2), CD45
(30-F11), CD4 (RM4-5) and CD8a (53-6.7), B220 (RA3-6B2),
CD11b (GL1), Gr-1 (RB6-8C5) (1:100; all from BD Biosciences)
and PE-anti mouse F4/80 (1:100, CI:A3-1, AbD Serotec). Red
blood cells were then removed with lysis buffer. Data were
collected using the BD FACSCanto II (BD Biosciences) and
analysed using FlowJo software (Tree Star Inc). CD45+ cells were
gated from the live cell population (SSC versus FSC). Leukocyte
subsets (CD4, CD8, B220, CD11b and Gr1) were then gated from
CD45+ cells.
Real-time RT-PCR
Total RNA was extracted from retinal tissue by RNeasy Mini
kit (Qiagen Ltd, Crawley, UK) and from cultured cells by
Trireagent (Sigma-Aldrich, Poole, UK) according to the manu-
facturer’s instructions. The quantity and quality of RNA were
determined using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE). The same amount
of total RNA was used for reverse transcription using Super-
ScripTM II Reverse Transcriptase kit and random primers
(Invitrogen).
Real-time RT-PCR was performed using SYBR Green Master
(Roche Diagnostics GmbH, Mannheim, Germany) in Light-
CyclerH 480 system (Roche Diagnostics GmbH). The primer
sequences are listed in table 1. Beta-actin and 18s were used as
retinae and BMDMs housekeeping controls respectively.
Results
CCL22/2CX3CR1GFP/GFP mice Develop Dry-AMD Like
Changes with Age
Under normal housing conditions, no fundus abnormalities
were observed in 3,6 months old CCL22/2CX3CR1GFP/GFP
mice (Figure 1A). Patches of yellowish/whitish lesions were
observed in 17–60% of 12-month old (Figure 1B, 1C), and 30–
100% of 18-month old (Figure 1D) CCL22/2CX3CR1GFP/GFP
mice in three studies (Table 2). The majority of lesions were
detected in the temporal area (both upper and lower) between
optic disc and equatorial region of the retina, and lesion size varies
from 0.5,5 optic disc diameter (Figure 1B–1E). Lesions were
rarely detected in the peripheral retinal areas. Light is considered
one of the main risk factors for AMD [43,44]. The average light
intensity inside the housing room was 200 lux. However, cages at
different locations received different levels of light exposure. The
average light intensity inside the cages located at the bottom layer
of the rack was 46 lux (12–125 lux), whereas the cages located at
the top layer had 180 lux (58–380 lux) light exposure. The levels of
light intensity inside the cage positively correlated to the incidence
of fundus lesion (Pearson, r = 0.993, P= 0.006, Table 2). None of
the WT mice developed retinal atrophic lesions under normal
housing conditions (Table 2).
The effect of light on retinal lesion development was further
confirmed by extra light exposure. When mice were exposed to
,800 lux light 6 h/day for 6,7 months, 83–100% of CCL22/
2CX3CR1GFP/GFP mice developed patches of yellowish and
whitish lesions (Table 3, Figure 1E). Interestingly 20–25% of WT
mice also developed retinal lesions after 800 lux chronic light
treatment (Table 3).
Figure 5. Immune response in WT and CCL22/2CX3CR1GFP/GFP mice. (A–C) flow cytometry analysis of blood cells (gated on CD45+ cells) from
3-month (A) and 18-month (B) old WT and CCL22/2CX3CR1GFP/GFP mice. (C) The expression levels of MHC-II (geo-mean) in CD45+ blood cells in
different groups of mice. (D) Real-time RT-PCR analysis of retinal gene expression. *, P,0.05; **,0.01 compared to WT mice, n = 6, unpaired Student t
test.
doi:10.1371/journal.pone.0061381.g005
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Indocyanine green angiography did not reveal any CNV in
normal aged or 800lux light treated CCL22/2CX3CR1GFP/GFP
mice (Figure 1G, 1H). When CNV was induced using 532 nm
diode laser, the size of the CNV did not differ significantly between
WT and CCL22/2CX3CR1GFP/GFP mice (Figures 2A, 2B).
Furthermore, RPE cells (Figure 2C) and BM-DMs (Figure 2D)
from WT and CCL22/2CX3CR1GFP/GFP mice express compa-
rable levels of VEGF.
Our results suggest that the deletion of CCL2 and CX3CR1
predisposes mice to age- and light-mediated retinal damage, but
does not affect pathogenic retinal angiogenesis.
RPE Damage and Photoreceptor Degeneration in Aged
and 800 Lux Chronic Light Exposed Mice
The effects of age and 800 lux chronic light exposure on RPE
morphology was assessed in flat mount preparations. F-actin was
uniformly expressed at the cell-cell junctions in RPE cells in 6,18-
month old WT mice (Figure 3A), and in 6-month old CCL22/
2CX3CR1GFP/GFP mice (data not shown). Patches of RPE
abnormality evidenced by altered cell junction, loss of hexagonal
tessellation and uneven distribution of F-action, were observed in
33% of 12-month old (Figure 3B) and 50% 18-month old
(Figure 3C) CCL22/2CX3CR1GFP/GFP mice maintained under
normal light-cycle conditions. The number of RPE lesion in-
creased with age (Figure 3G). RPE lesions were observed in all
light-treated CCL22/2CX3CR1GFP/GFP mice (n = 12 eyes,
Figure 3D), however only 20% WT mouse eyes developed RPE
lesion following 800 Lux light treatment (n = 20, Figure 3F).
Multiple vacuoles with different sizes were observed in Z-stack
confocal images in eyes from CCL22/2CX3CR1GFP/GFP mice
(Figures 3C–3E). On average 2.8360.48 lesions per eye were
observed in 800 Lux light treated CCL22/2CX3CR1GFP/GFP
mice and 1.3360.46 lesions per eye were detected in 18-month
old CCL22/2CX3CR1GFP/GFP mice housed under normal
lighting conditions (Figure 3G). In light treated WT mice,
approximately one lesion was detected in every three eyes
(0.360.14 lesions per eye, Figure 3G).
Semithin sections revealed multiple vacuolisations and pigment
loss in RPE cells from aged CCL22/2CX3CR1GFP/GFP mice
(Figure 3I) but not in age-matched WT controls (Figure 3H). Large
vacuoles, similar to that observed in RPE flatmount (Figure 3E)
were observed in light-treated CCL22/2CX3CR1GFP/GFP mice
(Figure 3J). Photoreceptor loss was observed in areas correspond-
ing to severe RPE damage (Figure 3J). Synaptophysin, a synaptic
vesicle glycoprotein, is expressed in the inner and outer plexiform
layers of the retina (Figure 3K). In aged CCL22/2CX3CR1GFP/
GFP mice, synaptophysin expression was extended to the outer
nuclear layer (ONL, arrows in Figure 3L) of areas related to
photoreceptor loss. Rhodopsin is located in photoreceptor outer
segments (OS) and the expression was similar between WT and
CCL22/2CX3CR1GFP/GFP mice at young ages (3–6 months, data
not shown). In 18 months old mice, extensive rhodopsin
expression was detected across the retina in the outer plexiform
layer (OPL), ONL and photoreceptor inner segments (IS) of
CCL22/2CX3CR1GFP/GFP (Figure 3N) but not WT mice
(Figure 3M). Moreover, cone arrestin expression was markedly
down-regulated throughout the retina of aged (18-month)
CCL22/2CX3CR1GFP/GFP mice (Figure 3P) but not in WT mice
(Figure 3O). GABA and GlyT1 immunohistochemistry was
performed to analyse amacrine cells at the inner retina. GlyT1
immunoreactivity showed similar morphology and stratification of
glycinergic amacrine cells in aged WT (Figure 3Q) and CCL22/
2CX3CR1GFP/GFP mice (Figure 3R). However, a marked re-
duction in GABA expression was found across the IPL in DKO
mice (compare Figures 3Q and 3R). The disrupted expressions of
rhodopsin, cone arrestin, and GABA were observed across the
entire retina of DKO mice, although the changes were more
intense in the areas correlated to photoreceptor loss. Overall, these
results suggest photoreceptor degeneration, synaptic structural
remodelling and amacrine cell changes in aged CCL22/
2CX3CR1GFP/GFP mice.
Electron transmission microscopy revealed an increased thick-
ness of Bruch’s membrane in aged CCL22/2CX3CR1GFP/GFP
mice (Figure 4B) compared to WT mice (Figure 4A, 4C). In
addition, mitochondrial damage (Figure 4D), RPE vacuolization
(Figure 4E) and photoreceptor damage (Figure 4F) were observed
in aged and light-treated CCL22/2CX3CR1GFP/GFP mice.
Although photoreceptor damage was more frequently observed
in corresponding RPE vacuolated area, photoreceptor inner
segment damage (arrows in Figure 4G) and outer segments
disorientation (arrowheads, Figure 4G) were also observed in areas
without RPE vacuolation.
Retinal Immune Activation in CCL22/2CX3CR1GFP/GFP
Mice
Flow cytometry analysis of blood samples showed that WT and
CCL22/2CX3CR1GFP/GFP mice had comparable levels of
various immune cells in both young (3-month, Figure 5A) and
aged (18-month, Figure 5B) groups. The expression level of MHC-
II in CD11b+ cells from aged CCL22/2CX3CR1GFP/GFP mice
was slightly increased; however, the increment was not statistically
significant (Figure 5C).
Figure 6. Retinal GFAP expression in WT and CCL22/
2CX3CR1GFP/GFP mice. Cryosections of mouse eyes were stained for
GFAP (red) and DAPI (blue) and observed by confocal microscopy. (A) 3-
month WT mice. (B) 3-month CCL22/2CX3CR1GFP/GFP mice. (C) 18-
month WT mice, (D) 18-month CCL22/2CX3CR1GFP/GFP mice. GL,
ganglion layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale
bar = 20 mm.
doi:10.1371/journal.pone.0061381.g006
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To understand whether the combined deletion of CCL2 and
CX3XR1 affects retinal immune activation, genes involved in
inflammation (iNOS, TNFa, NLRP3, IL-1b), complement acti-
vation (C3, CFB,CFH, C1qb, C1INH, CD59a) and wound
healing or tissue remodelling (Arg-1, VEGFa) were selected for
quantitative PCR analysis. In addition, chemokines CCL2, CCL5,
CXCL2, CXCL10 (IP10), CXCL12 (SDF-1), and CX3CL1 that
are known to be expressed by neuronal tissue and are involved in
macrophage/microglial function were also selected. Increased
mRNA expression was observed in a number of immune related
genes in the retinas of CCL22/2CX3CR1GFP/GFP mice compared
to those of WT mice (Figure 5D). The upregulated genes include
Arg-1, iNOS, NLRP3, TNFa, VEGF, CXCL10 (IP-10), CXCL12
(SDF-1), CX3CL1, C1qb, C1NIH, and CD59a (Figure 5D). In-
terestingly, the expression of chemokine CXCL2 was reduced in
CCL22/2CX3CR1GFP/GFP mouse retinae (Figure 5D).
Immunofluorescent investigation of retinal sections showed that
GFAP was expressed in the ganglion layer in 3-month old WT
(Figure 6A) and CCL22/2CX3CR1GFP/GFP mice (Figure 6B),
although expression in the latter slightly extended to the inner
nuclear layer (INL, Figure 6B). In aged (18-month) WT (Figure 5C)
and CCL22/2CX3CR1GFP/GFP mice (Figure 5D) the expression
was significantly increased and extended to the outer nuclear
layers. The increment was more significant in aged CCL22/
2CX3CR1GFP/GFP mice (Figure 6D) compared to WT mice
(Figure 6C).
In CCL22/2CX3CR1GFP/GFP mice, all microglial cells are
GFP+. Confocal microscopy of retinal flatmounts showed that the
number of microglial cells in both inner plexiform layer (IPL,
Figures 7A, 7C,7E) and outer plexiform layer (OPL, Figure 7B,
7D, 7F) increased in 18-month old CCL22/2CX3CR1GFP/GFP
mice, and chronic light-treatment resulted in significantly more
microglial cells in the retina (Figure 7G). Furthermore, microglial
cells in aged and chronic light-treated mice displayed shorter and
larger dendrites and had bigger somas (Figure 7H) compared to
microglia from 3-month old DKO mice (Figure 7I) and WT mice
(Figure 7J). Microglial cells in chronic light-treated mice also
expressed high levels of isolectin B4 (Figures 7E, 7F). Although all
microglia cells in chronic light-treated mice displayed active
morphology, the expression levels of isolectin B4 differed greatly in
different cells (Figures 7E, 7F), suggesting heterogeneous pheno-
type of retinal microglia. In chronic light-treated mice, 15% of
Figure 7. Retinal microglial activation in different ages of CCL22/2CX3CR1GFP/GFP mice. (A–F, K–M) Retinal flatmounts from DKO mice
were stained for isolectin B4 (red) and examined by confocal microscopy. (A, C, E) Confocal images from inner plexiform layer (IPL). (B, D, F) Confocal
images from outer plexiform layer (OPL). (A, B) 3-month old. (C, D), 18-month old. (E, F) 10-month+light-treatment. (G) The number of microglial cells
in different groups of mice. (H) High magnification image showing activated microglia from light-treated mice. (I) High magnification image showing
a naive resident microglia from a 3-month old DKO mouse. (J) High magnification image showing a CD11b+ naı¨ve resident microglia from a 3-month
old WT mouse. (K–M) Z-axils reconstruction of confoal z-stack images from a 3-month old (K), an 18-month old (L), and 10-month+light CCL22/
2/CX3CR1GFP/GFP (M) mouse retina. (N–Q) RPE/choroidal flatmounts showing subretinal macrophages in a 3-month old (N), an 18-month old (O), and
10-month+light (P, Q) CCL22/2/CX3CR1GFP/GFP mouse eyes. RPE cells were stained with rhodamine-phalloidin (red). (R) The number of subretinal
macrophages in different groups of mice. *, P,0.05; **,0.01, n = 6. GL, Ganglion layer; PL, photoreceptor layer. Scale bar = 50 mm.
doi:10.1371/journal.pone.0061381.g007
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microglial cells contained one or more vacuoles (Figure 7H),
possibly indicative of active phagocytosis. The aforementioned
microglial activation was observed throughout the neuronal retina
of aged and light-treated DKO mice.
Figure 8. Macrophage phenotype and function in CCL22/2CX3CR1GFP/GFP DKO mice. Bone marrow-derived macrophages (BM-DMs) were
cultured from WT and CCL22/2CX3CR1GFP/GFP mice (see Materials & Methods). Cells were then used for gene expression and phagocytosis assay. In
some experiments, BM-DMs were further polarized into M1 (with LPS) or M2 (with IL-4) macrophages. (A) Flow cytometry analysis showing F4/80 and
CD11b expression in BM-DMs. (B) Real-time RT-PCR analysis of immune related genes in undifferentiated M0 macrophages from WT and DKO mice
under normoxia culture condition. Gene expression level was normalised by housekeeping gene (18s). (C) Real-time RT-PCR analysis of immune
related genes in different subsets of BM-DMs (M0, M1, and M2) from WT and DKO mice under hypoxia conditions (1% oxygen). Data shown are mRNA
fold changes versus WT M0 BM-DMs under normoxia conditions. *, P,0.05; **,0.01, compared WT BM-DMs, n = 3. (D) Phagocytosis of M0 BM-DMs
from WT and DKO mice determined by the pHrodoTM E. coli BioparticlesH Phagocytosis assay. *, P,0.05; **,0.01, compared to DKO BM-DMs at the
same time point. N = 6.
doi:10.1371/journal.pone.0061381.g008
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When the whole thickness of the retina was scanned in z-stack
images, GFP+ microglial cells were observed in ganglion layer
(GL), IPL and OPL in 3-month old mice (Figure 7K). However, in
18-month old mice, many dendrites, and occasionally cell bodies
were observed in the photoreceptor layer (PL, Figure 7L). In
chronic light-treated mice, many more dendrites, some of which
also express high levels of isolectin B4, were detected in the
photoreceptor layer (Figure 7M).
In 3-month old CCL22/2CX3CR1GFP/GFP mice, a few GFP+
microglial cells were detected in RPE/choroidal flatmounts
(Figure 7N), and the number of subretinal microglia increased
significantly in 18-month CCL22/2CX3CR1GFP/GFP mice
(Figures 7O, 7R). Many more subretinal macrophages were
detected in the eyes from chronic light-treated CCL22/
2CX3CR1GFP/GFP mice (Figures 7 P–R). At the RPE lesion sites
macrophages displayed small cell bodies and less or no dendrites
(Figure 7Q).
The results suggest that deletion of CCL2 and CX3CR1 results
in a greater retinal immune activation under chronic stress
conditions.
Altered Immune Activation in Bone Marrow–Derived
Macrophages of CCL22/2CX3CR1GFP/GFP Mice
To further understand the underlying mechanism related to
enhanced retinal immune activation in CCL22/2CX3CR1GFP/
GFP mice, we investigated the immune function of myeloid-derived
cells. The phenotype of bone marrow-derived macrophages (BM-
DMs) from WT and CCL22/2CX3CR1GFP/GFP mice did not
differ (Figure 8A). They also expressed similar levels of various
immune mediators, including iNOS, Arginase-1, IL-6, IL-1b, IL-12
(p40) and IL-10 (Figure 8B). The retina has the lowest levels of
oxygen tension in the body (PO2:5–25 mmHg in the retina
compared to 85–90 mmHg in systemic arterial circulation) and is
considered to have a hypoxic microenvironment [45]. To mimic
the in vivo situation, we cultured BM-DMs under hypoxic
conditions (1% O2). Interestingly, BM-DMs from CCL2
2/
2CX3CR1GFP/GFP mice expressed significantly higher levels of
iNOS, IL-6, IL-1b, IL-12, and IL-10, particularly when they were
polarized to a classically activated inflammatory macrophage
phenotype with LPS (M1) or alternatively activated wound-healing
macrophage with IL-4 (M2) (Figure 8C). In addition, BM-DMs
from CCL22/2CX3CR1GFP/GFP mice also had significantly
reduced phagocytic activity compared to those from WT mice
(Figure 8D).
The results suggest that the deletion of CCL2 and CX3CR1
results in greater immune activation but lower scavenging activity
in myeloid-derived cells under stress conditions.
Discussion
In 2007, Tuo et al reported that the combined deletion of
chemokine Ccl2 and Fractalkine receptor Cx3cr1 on C57BL/6N
genetic background (i.e., CCL22/2CX3CR12/2 mice) resulted in
an early onset of spontaneous retinal degeneration with AMD-like
features such as RPE alteration, photoreceptor damage and A2E
elevation [30], and the mouse has been considered as a valuable
model of AMD [46]. A recent study has shown that the C57BL/
6N mice have Crb-1 rd8 mutation [31], and it has been suggested
that retinal lesions in the Ccl22/2Cx3cr12/2 mice may be caused
by rd8 mutation rather than Ccl2 and Cx3cr1 deletion [31,32].
Further, Vessey et al observed inner retinal dysfunction related to
amacrine abnormality but no retinal degeneration in adult (up to 9
months) DKO mice [35]. More recently, Luhmann et al reported
that when mice were housed under dim conditions (33 lux light
intensity), none of the genetically modified mice, including CCL2
KO, CX3CR1 KO and CCL2/CX3CR1 DKO developed retinal
degeneration by the age of 12–14 months [34]. In this study, we
show that CCL22/2CX3CR1GFP/GFP mice on C57BL/6J genetic
background age-dependently develop localised retinal atrophy,
akin to human GA, and the minimal age of developing GA-like
lesions is 12 months. Chronic light exposure further enhances the
size and number of retinal lesions (Figure 3G). Since our mice do
not have Crb-1 rd8 mutation, our results suggest that the deletion of
Ccl2 and Cx3cr1 predisposes mice to retinal atrophy under aging
and chronic light damage conditions more so than in the single
CCL2 or CCR2 knockout mice [28,29]. Inner retinal (amacrine
cell) abnormalities were also observed in our study. An explanation
for the discrepancies in our data on outer retinal degeneration in
the DKO mice and that of others remains elusive. It is possible
that different animal housing conditions and different techniques
used to detect lesions may be responsible for the different results.
CCL2-CCR2 and CX3CL1-CX3CR1 are important chemokine
pathways involved in various immune responses. Immune
responses only occur when tissues suffer from exogenous pathogen
invasions or endogenous ‘‘danger’’ insults. Luhmann et al housed
their mice under dim conditions (33 Lux light intensity) [34]. The
low levels of light exposure may not cause sufficient oxidative
damage to the eye even up to 12–14 months of age. In the absence
of retinal insults, inflammation will not occur and the effects of
CCL2 or CX3CR1 deletion will not be detectable. Furthermore,
we detected 1.33 lesions/eye (with an average size equivalent to
that of the optic disc) in 18 month old mice housed under normal
lighting conditions by confocal microscopy of RPE flatmounts
(Figure 3G). The low numbers of small lesion can easily be missed
in retinal histological investigations (the techniques that other
studies applied).
Oxidative damage is considered one of the triggers for age-
related retinal degeneration. A healthy immune system helps to
remove damaged molecules and dead cells and to promote tissue
remodelling by mounting a para-inflammatory response [47].
Under normal aging conditions, if the level of age-related retinal
damage and the homeostatic capacity of para-inflammation are
balanced, the risk of retinal pathology may be avoided. We have
shown previously that age-related retinal para-inflammatory
responses are expressed by resident microglia and RPE cells [24]
as well as bone marrow-derived myeloid cells [27]. Increased
oxidative damage resulting from environmental risk factors may
break the balance leading to lesion development. By exposing mice
to 800 Lux additional lights, the levels of oxidative stress to the
retina were increased. In WT mice, where the para-inflammatory
response is tightly controlled, the majority of mice were able to
maintain retinal homeostasis (evidenced by the low incidence of
disease and low number of lesions (0.3060.14). All light-treated
CCL22/2CX3CR1GFP/GFP mice developed GA-like lesions and
more lesions occurred in each eye (2.8360.48). It appears that the
cumulative effect of age, light damage and Ccl2/Cx3cr1 gene
deletions combine to break the balance and increase the likelihood
of GA-like lesions.
In addition to oxidative insults, dysfunction in any of the cells
involved in retina para-inflammation, or dysregulation of any of
the immune responses may also disturb the balance resulting in
GA-like lesions in the aging retina. Under normal housing
conditions, the systemic immunological parameters between WT
and CCL22/2CX3CR1GFP/GFP mice did not differ, whereas
retinal immune response was significantly increased in CCL22/
2CX3CR1GFP/GFP mice as compared to that in WT mice. The
CX3CL1-CX3CR1 pathway is known to play an important role
in regulating microglial activation [48], and is neuroprotective
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[48,49]. More recently, we have shown that in the absence of
CX3CR1, ischemia and oxidative damage-mediated retinal de-
generation is accelerated [50]. The lack of CX3CR1 may be
responsible for the increased microglial activation and retinal
degeneration in the DKO mice under ageing and light exposure
conditions. In addition, we detected increased levels of CXCL10
(IP-10) and CXCL12 (SDF-1) in DKO mouse retina (Figure 5).
Although the underlying mechanism related to over expression of
these CXC chemokines remains elusive, they may be involved in
excessive retinal microglial activation. The contribution of CCL2
depletion to age- and light-mediated retinal degeneration may be
related to altered monocyte and macrophage function in these
mice. Previously, we have shown that macrophages from CCL2
KO mice express excessive amounts of inflammatory mediators
such as inducible nitric oxide synthase (iNOS) and TNF-a [28]. In
this study, TNF-a (along with chemokines CXCL10 and
CXCL12) mRNA expression was significantly increased in
DKO mouse retina (Figure 5). Although under normal culture
conditions, BM-DMs from WT and CCL22/2CX3CR1GFP/GFP
mice had a similar phenotype and expressed comparable levels of
inflammatory cytokines/chemokines, when these cells were
cultured under hypoxic conditions (1% O2), cells from CCL2
2/
2CX3CR1GFP/GFP mice expressed significantly higher levels of
inflammatory mediators (Figure 8). The retina has the highest
metabolic activity within the body, and is constantly exposed to
relatively hypoxic conditions [45]. The retina may also suffer from
higher levels of oxidative stress compared to other tissues due to
sustained light exposure. Our results suggest that the combined
deletion of Ccl2 and Cx3cr1 results in aggressive inflammatory
responses by monocytes and macrophages under hypoxia and
stress-related conditions.
Bone marrow-derived macrophages from CCL22/
2CX3CR1GFP/GFP mice have significantly reduced phagocytic
activity compared to those from WT mice. Previously, we have
observed similar phenomena in CCL2 KO and CCR2 KO mice
[28]. CCL2-CCR2 pathway may contribute to altered myeloid
cell function in CCL22/2CX3CR1GFP/GFP mice. The physiolog-
ical role of para-inflammation is to remove damaged molecules
and dead cells to maintain tissue homeostasis [24,47], and
phagocytosis is essential to achieve this goal. Although mono-
cytes/microglial cells in CCL22/2CX3CR1GFP/GFP mice are
more active than cells in WT mice, they are less capable of
removing damaged molecules and dead cells. Instead, they may
produce higher levels of inflammatory mediators such as nitric
oxide, IL-1b, and TNF-a, which may further damage tissue cells
contributing to lesion development. Thus a possible explanation
for the increased damage is one of dysregulated para-inflammatory
responses in the DKO mice since they are less able to deal with the
challenges of light exposure and age as well as WT mice.
RPE cell damage presents as localised ‘‘patchy’’ retinal lesions
in this model. A recent study by Tarallo et al has shown that Alu
RNAs (related to the loss of DICER1) induced NLRP3
inflammasome activation and its related IL-18 production play
a key role in RPE cell death in GA [51]. In addition to Alu RNA,
oxidised lipid can also activate NLRP3 inflammasome in RPE cells
[52]. In this study, we detected an increased NLRP3 mRNA
expression in aged WT and DKO mouse RPE compared to young
mouse retina (data not shown). However, there is no significant
difference between WT and DKO mouse retinas. Further studies
are needed to understand whether excessive inflammasome
activation exists in DKO RPE cells, and such studies are on-
going in the investigators’ laboratory.
In summary, in this study, we show that disruption in the
balance between the level of age-related retinal oxidative insults
and the homeostatic capacity of the retinal para-inflammatory
response to deal with them results in localised retinal atrophic
lesions. More importantly, our data suggest that altered immune
functions in the forms of uncontrolled microglial activation,
reduced phagocytosis and increased inflammatory gene expression
in immune cells may contribute to the development of a GA-like
lesion during aging. Although AMD patients do not have CCL2
and CX3CR1 deficiency, many of them do have other immune-
related gene polymorphisms, including genes involved in the
complement system [53], TLRs [15,54], and CX3CR1 [16,17,19].
Alterations in these genes may affect physiological ‘‘housekeeping’’
functions of innate immune cells such as phagocytosis of apoptotic
dead cell debris and inflammatory gene expression, which may
result in dysfunction or dysregulation of retinal para-inflammatory
mechanisms [47], and ultimately AMD lesion development. While
the current experiments go some way towards supporting this
concept, we recognise that there are a number of limitations to the
model. Firstly, the GA-like lesion mirrors only part of dry AMD
pathology (e.g. RPE cell death and photoreceptor degeneration),
and we did not observe drusen. Secondly, under normal ageing
conditions only 50% of the mice develop the disease and the
number of lesions in each eye is low. Therefore, specialised
techniques such as RPE flatmount confocal microscopy are
required to detect the lesion. However, the fact that the incidence
and severity of disease can be manipulated by altering environ-
mental risk factors known to be associated with AMD (e.g. light)
suggests that comparable mechanisms are at play in this model as
in human AMD. Therefore, we believe that despite the limitations,
the CCL22/2CX3CR1GFP/GFP mouse is a useful model to dissect
the immunopathogenesis of and to test therapeutic agents in dry
AMD.
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